To test this, we performed immunohistochemistry against CD163, a putative M2-polarisation marker and TREM2, a protein associated with immunosuppressive activity in tumour-associated microglia/macrophages (Fig. 2b, Additional File 1: Table S12) [38, 40, 43]. This evidence concerns the gene TREM2 and neoplasm.